b
r
c
r
c
l
e
n
f
zika
viru
zikav
classic
describ
caus
minor
symptom
adult
patient
howev
neurolog
complic
recogn
recent
outbreak
central
south
america
result
seriou
ill
adult
patient
report
adult
patient
latin
america
diagnos
zikav
infect
admit
intens
care
unit
icu
method
multicent
prospect
case
seri
adult
patient
laboratori
diagnosi
zikav
icu
countri
march
first
autochthon
transmiss
zika
viru
zikav
describ
continent
south
america
flaviviru
like
origin
uganda
presum
migrat
eastward
march
countri
region
america
sinc
report
confirm
case
transmiss
epidem
provid
crucial
timesensit
opportun
understand
epidemiolog
new
emerg
infecti
threat
use
prior
experi
sever
influenza
dengu
outbreak
organ
network
sentinel
intens
care
unit
icu
latin
american
countri
detect
critic
ill
patient
diagnosi
zikav
requir
admiss
icu
laboratori
confirm
case
epidem
outbreak
difficult
particularli
middleor
lowincom
countri
accord
panamerican
health
organ
paho
major
case
zikav
suspect
case
countri
report
databas
minor
laboratori
confirm
best
test
confirm
infect
revers
transcript
polymeras
chain
reaction
rtpcr
serum
cerebrospin
fluid
without
disadvantag
although
first
report
limit
use
analyz
serum
day
infect
recent
data
challeng
assert
set
median
percentil
time
loss
posit
day
ci
day
ci
respect
pazbailey
g
rosemberg
es
doyl
k
et
al
persist
zika
viru
bodi
fluidspreliminari
report
n
engl
j
med
februari
case
diagnos
clinic
epidemiolog
basi
use
protocol
case
definit
establish
countri
accord
definit
clinic
zikav
infect
typic
milder
present
compar
aedesrel
viral
infect
howev
increasingli
recogn
caus
seriou
ill
particularli
case
identifi
epidem
evid
support
relationship
zikav
infect
fetal
microcephali
guillainbarr
syndrom
gb
myeliti
increas
microcephali
children
infect
mother
dramat
manifest
neurotrop
viru
variou
neurolog
disord
increasingli
recogn
affect
host
french
polynesia
total
case
gb
record
zikav
outbreak
estim
risk
case
per
zikav
infect
case
myeliti
describ
acut
phase
infect
gb
commonli
postinfecti
complic
descript
clinic
featur
new
emerg
diseas
challeng
might
requir
gather
data
concurr
epidem
outbreak
present
studi
focu
detect
describ
sever
medic
complic
caus
zikav
infect
adult
short
period
incid
multicent
prospect
observ
studi
admit
patient
particip
hospit
intens
care
unit
icu
diagnosi
zikav
describ
clinic
present
demograph
featur
evolut
critic
ill
adult
patient
admit
icu
recent
diagnosi
zikav
infect
surveil
network
countri
latin
america
develop
network
sentinel
icu
particip
latin
american
countri
detect
critic
ill
patient
diagnosi
zikav
decemb
april
recruit
critic
ill
adult
patient
admit
particip
icu
recent
diagnosi
zikav
infect
establish
confirm
diagnosi
patient
test
posit
rtpcr
zikav
exclud
patient
without
laboratori
confirm
plausibl
altern
diagnosi
clinic
demograph
data
collect
use
onlin
case
report
form
modifi
intern
sever
acut
respiratori
emerg
infect
consortium
isar
modif
relev
critic
ill
patient
diagnosi
treatment
neurolog
complic
case
report
form
made
avail
particip
icu
googl
form
data
pool
googl
drive
data
record
excel
analyz
use
stata
v
colleg
station
texa
usa
quantit
variabl
present
measur
central
tendenc
dispers
appropri
data
distribut
categor
variabl
present
count
intern
ethic
guidelin
biomed
research
human
be
follow
ciom
intervent
purpos
modif
biolog
physiolog
psycholog
social
variabl
intend
consid
exempt
risk
research
inform
consent
requir
data
obtain
anonym
assign
differ
code
hospit
record
never
pose
risk
profession
confidenti
agreement
research
occur
context
zikav
outbreak
protocol
defin
one
case
report
form
crf
informationgath
instrument
decemb
april
icu
countri
enrol
critic
ill
patient
diagnosi
zikav
infect
colombia
venezuela
salvador
guatemala
puerto
rico
ecuador
peru
chile
diagnosi
zikav
establish
rtpcr
patient
serum
cerebrospin
fluid
elisa
patient
serum
use
clinicalepidemiolog
criteria
remain
patient
patient
diagnost
confirm
rtpcr
includ
fig
baselin
characterist
describ
tabl
elisa
detect
igm
neg
dengu
human
immunodefici
viru
hiv
cytomegaloviru
hepat
epstein
barr
viru
herp
simplex
viru
except
one
case
posit
dengu
test
chikungunya
campylobact
jejunii
mycoplasma
pneumonia
made
lesser
frequenc
seven
patient
still
erupt
time
admiss
requir
definit
zikav
infect
case
one
prurit
seen
convalesc
period
viral
diseas
like
dengu
tabl
nine
patient
came
urban
area
patient
rural
area
three
report
zikalik
ill
famili
member
eight
patient
diagnos
gb
intensivist
neurologist
follow
brighton
criteria
two
patient
diagnos
enceph
neurologist
accord
clinic
radiolog
criteria
indic
icu
admiss
respiratori
insuffici
due
neuromuscular
weak
alter
level
conscious
one
septic
shock
tabl
median
time
laps
initi
symptom
admiss
day
iqr
median
stay
uci
day
iqr
median
time
initi
symptom
neurolog
nadir
iqr
median
hospit
stay
day
iqr
tabl
total
patient
requir
intub
mechan
ventil
radiograph
describ
normal
respiratori
insuffici
origin
neuromuscular
weak
one
requir
addit
nasal
high
flow
oxygen
stay
icu
stay
four
confirm
patient
receiv
intraven
vasoact
drug
shock
half
requir
norepinephrin
dose
n
tabl
six
patient
treat
immunoglobulin
plasmapheresi
tabl
lumbar
punctur
lp
perform
patient
mean
time
laps
onset
symptom
procedur
day
cerebrospin
fluid
csf
analysi
reveal
pleocytosi
two
also
increas
protein
glucos
normal
three
patient
underw
electromyographi
emg
find
consist
demyelin
polyneuropathi
one
axon
polyneuropathi
mix
last
tabl
fig
show
patient
emg
eight
patient
underw
brain
imag
three
magnet
reson
imag
mri
six
comput
tomograph
ct
imag
one
mri
report
patholog
hyperintens
lesion
frontal
tempor
cortic
region
bilater
subcort
involv
persist
axial
flair
render
sequenc
compat
inflammatori
lesion
characterist
encephalitisrhomboenceph
fig
one
ct
scan
show
sign
suggest
brain
swell
imag
studi
normal
two
patient
clinic
pictur
compat
enceph
one
patient
diagnos
show
suggest
find
mri
describ
lp
lymphocytesmm
elev
protein
normal
glucos
posit
rtpcr
zikav
csf
elevenday
stay
icu
patient
discharg
neurolog
disabl
admit
diminish
level
conscious
abnorm
ct
describ
die
less
week
icu
median
rankin
scale
discharg
iqr
mean
signific
disabl
two
patient
die
one
diagnos
gb
subsequ
multisystem
organ
failur
enceph
neurolog
deficit
respons
icu
admiss
persist
discharg
one
case
nevertheless
one
patient
suffer
sever
disabl
bedridden
incontin
requir
constant
nurs
care
tabl
author
studi
popul
patient
whose
ill
suffici
sever
merit
icu
admiss
fortynin
patient
identifi
icu
latin
america
howev
case
diagnos
confirm
rtpcr
presum
due
technolog
limit
differ
countri
patient
admit
period
epidemiolog
week
present
gb
accord
brighton
criteria
two
die
one
due
enceph
one
septic
shock
whopaho
report
peak
incid
zikav
infect
epidemiolog
week
consist
observ
micronesia
case
began
occur
week
later
compar
demograph
data
recent
data
pernambuco
brazil
show
similar
report
although
age
group
frequent
affect
zikavrel
gb
patient
fourth
decad
attack
rate
higher
patient
age
flavivirus
includ
dengu
viru
previous
shown
occasion
develop
neurolog
complic
patient
confirm
rtpcr
common
present
ascend
weak
hyporreflexiaarreflexia
consist
brighton
criteria
gb
time
appear
symptom
neurolog
deterior
day
neurolog
fig
magnet
reson
brain
confirm
patient
case
diagnos
enceph
associ
zika
viru
infect
show
hyperintens
lesion
frontal
tempor
region
bilater
addit
subcort
damag
found
predominantli
right
side
find
compat
diagnosi
enceph
nadir
reach
median
day
consist
gb
report
h
day
nevertheless
csf
analysi
show
patient
pleocytosi
none
albumincytolog
dissoci
increas
csf
protein
level
without
correspond
increas
cellular
content
characterist
gb
previou
report
zikavgb
show
similar
time
onset
viral
symptom
neurolog
deterior
day
spite
patient
present
still
viraem
admiss
establish
rtpcr
whether
look
subset
patient
differ
present
gb
still
far
settl
three
case
underw
electromyographi
two
report
suffer
acut
demyelin
polyneuropathi
one
axon
motor
polyneuropathi
contrast
report
recent
public
colombia
french
polynesia
axon
motor
neuropathi
predomin
could
due
earlier
acquisit
studi
could
later
shown
differ
result
previous
report
caolormeau
vm
et
al
although
variabl
median
icu
stay
iqr
although
data
regard
zikavrel
gb
particular
shorter
two
three
week
describ
patient
gb
need
ventil
support
higher
requir
intub
mechan
ventil
due
muscular
failur
higher
previous
report
zikav
type
gb
also
patient
receiv
intraven
vasoact
medic
hypotens
greater
proport
describ
gb
worth
note
outcom
heterogen
attribut
extent
limit
sampl
surviv
gb
patient
degre
motor
incapac
minim
time
departur
except
one
similar
previou
public
mortal
group
similar
previou
report
two
patient
suspect
enceph
one
discharg
without
disabl
die
studi
benefit
establish
latin
american
critic
care
trial
investig
network
lacctin
provid
platform
collabor
amongst
investig
geograph
dispers
area
intern
forum
acut
care
trialist
infact
provid
methodolog
support
mentorship
studi
inde
larg
investigatorl
research
consortia
proven
import
initi
character
novel
infecti
threat
influenza
merscov
ebola
zikav
avail
valid
readytous
case
report
form
intern
sever
acut
respiratori
emerg
infect
consortium
isar
facilit
rapid
launch
data
collect
studi
present
number
limit
case
report
discard
due
lack
rtpcr
confirm
scarciti
resourc
technolog
limit
certain
countri
especi
epidem
play
major
role
determin
diagnost
protocol
addit
workup
gb
insuffici
undermin
certainti
diagnosi
case
data
collect
retrospect
even
key
element
may
miss
due
complex
nascent
intern
collabor
particip
studi
voluntari
unfund
claim
establish
region
burden
sever
zikav
infect
period
report
furthermor
lack
reliabl
preval
data
estim
risk
sever
ill
amongst
infect
patient
summari
show
zikav
uncommon
neurolog
complic
sever
enough
warrant
icu
admiss
present
realli
heterogen
popul
patient
concord
zikavgb
describ
previous
caolormeau
vm
et
al
patient
still
viraem
present
someth
previous
report
warrant
investig
enceph
much
rare
also
lethal
present
emerg
infect
import
understand
spectrum
present
zikav
infect
current
outbreak
expand
studi
report
adult
critic
ill
patient
diagnosi
zikav
confirm
requir
admiss
icu
due
lifethreaten
complic
seri
zikav
associ
spectrum
neurolog
present
commonli
gbslike
syndrom
also
enceph
suggest
one
potenti
pathophysiolog
mechan
import
clinic
followup
patient
suspect
zikav
consid
etiolog
amongst
patient
present
neurolog
symptom
larger
populationbas
observ
studi
patient
zikav
need
help
identifi
risk
factor
sever
ill
may
better
counsel
patient
prepar
health
care
system
